Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in...

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Schizophrenia is associated with impaired probabilistic association learning and abnormal brain activity.
• Selective estrogen receptor modulators (SERMs) like raloxifene show potential in improving memory and neural activity in schizophrenia.

Purpose of the Study:

• To investigate the effects of raloxifene on neural activity during probabilistic association learning in individuals with schizophrenia.
• To determine if raloxifene can enhance learning and associated brain function in schizophrenia patients.

Main Methods:

• A 12-week randomized, double-blind, placebo-controlled, cross-over trial involving 19 individuals with schizophrenia.
• Functional magnetic resonance imaging (fMRI) was used to measure brain activity during a probabilistic association learning task.
• Raloxifene was administered orally at 120 mg daily as an adjunctive treatment.

Main Results:

• Raloxifene significantly improved probabilistic association learning compared to placebo.
• fMRI revealed that raloxifene increased blood-oxygen-level-dependent (BOLD) activity in the hippocampus and parahippocampal gyrus.
• A correlation was observed between parahippocampal neural activity and learning in patients, but not in healthy controls.

Conclusions:

• Selective estrogen receptor modulation with raloxifene enhances probabilistic association learning in schizophrenia.
• Raloxifene increases neural activity in the hippocampus and parahippocampal gyrus, suggesting a role in remediating learning deficits.
• Estrogen receptor modulation may be a viable therapeutic strategy for learning disabilities in both men and women with schizophrenia.